Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug;16(4):817-818.
doi: 10.1007/s13193-025-02369-7. Epub 2025 Jul 21.

From the Desk of Editors: Omission of Surgery in Breast Cancer? Step Forward or Detour

Pankaj Kumar Garg  1 , Nita Nair  2 , S P Somashekhar  3
Affiliations
Editorial

From the Desk of Editors: Omission of Surgery in Breast Cancer? Step Forward or Detour

Pankaj Kumar Garg et al. Indian J Surg Oncol. 2025 Aug.
No abstract available

PubMed Disclaimer

References

    1. Kuerer HM, Valero V, Smith BD et al (2025) Selective elimination of breast surgery for invasive breast cancer: a nonrandomized clinical trial. JAMA Oncol. 10.1001/jamaoncol.2025.0207 - PMC - PubMed
    1. Ranganath R, Hui M, Uppin S, Jena S, Shantappa R (2023) An audit of breast conservation surgery for breast cancer—a 7-year experience from Southern India. Indian J Surg Oncol 14:492–496. 10.1007/s13193-022-01532-8 - PMC - PubMed
    1. Singh AP, Seenu V, Krishna A, Radhakrishnan L (2024) Local flaps in breast-conserving surgery in early breast cancer patients: armamentarium for breast surgeon. Indian J Surg Oncol 15:258–263. 10.1007/s13193-024-01880-7 - PMC - PubMed
    1. van Loevezijn AA, van der Noordaa MEM, van Werkhoven ED et al (2021) Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): interim analysis of a multicenter observational cohort study. Ann Surg Oncol 28:3243–3253. 10.1245/s10434-020-09273-0 - PMC - PubMed
    1. Basik M, Cecchini RS, De Los Santos JF et al (2025) Breast tumor-bed biopsy for pathological complete response prediction: the NRG-BR005 nonrandomized clinical trial. JAMA Surg. 10.1001/jamasurg.2025.1072 - PMC - PubMed

Publication types